Peijia Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	761.12	536.73	666.74	795.77	1,670	2,296
Short-Term Investments	-	23.53	31.04	70	1.87	1.93
Trading Asset Securities	-	-	14.75	77.16	71.56	-
Cash & Short-Term Investments	761.12	560.26	712.52	942.93	1,743	2,298
Cash Growth	26.48%	-21.37%	-24.44%	-45.91%	-24.15%	-6.72%
Accounts Receivable	125.56	46.19	101.04	80.21	12.6	-
Other Receivables	-	-	-	-	63.26	31.41
Receivables	125.56	46.19	101.04	80.21	75.86	31.41
Inventory	152.5	153.52	156.8	170.65	173.19	85.97
Restricted Cash	50	50	-	-	-	-
Other Current Assets	21.39	11.82	16.64	43.71	15.3	10.95
Total Current Assets	1,111	821.79	987	1,237	2,007	2,426
Property, Plant & Equipment	738.75	757.42	695.76	498.61	327.44	176.22
Long-Term Investments	316.01	337.28	326.81	387.06	415.49	224.42
Goodwill	51.66	51.66	51.66	51.66	51.66	51.66
Other Intangible Assets	622.71	632.78	574.77	476.22	487.29	224.84
Long-Term Deferred Charges	59.09	46.98	29.57	-	-	-
Other Long-Term Assets	15.4	8.88	23.14	20.94	13.33	60.16
Total Assets	2,914	2,657	2,689	2,672	3,316	3,164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	42.88	68.14	25.72	19.71	361.58	54.17
Accrued Expenses	38.45	74.42	63.82	57.61	50.48	24.49
Short-Term Debt	388.39	390.66	89.78	13.83	56.06	-
Current Portion of Leases	1.96	2.69	2.09	2.59	2.89	3.55
Current Income Taxes Payable	32.11	-	1.27	-	15.27	5.39
Other Current Liabilities	210.14	142.81	260.02	60.52	91.75	31.12
Total Current Liabilities	713.92	678.73	442.7	154.25	578.02	118.71
Long-Term Debt	260.71	37.98	158.31	203.59	70.77	-
Long-Term Leases	1.63	2.7	3.22	1.13	2.15	4.08
Long-Term Unearned Revenue	22.54	20.11	20.77	13.1	1.72	1.37
Long-Term Deferred Tax Liabilities	23.07	16.49	16.78	20.32	20.32	20.32
Other Long-Term Liabilities	38.51	42.7	2.32	5.49	5.87	-
Total Liabilities	1,060	798.71	644.11	397.88	678.86	144.48

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.48	0.47	0.47	0.48	0.48	0.47
Additional Paid-In Capital	6,335	6,332	6,323	6,359	6,369	6,339
Retained Earnings	-	-	-	-	-3,713	-3,305
Treasury Stock	-	-	-	-	-82.74	-84.55
Comprehensive Income & Other	-4,494	-4,488	-4,296	-4,085	63.62	69.14
Total Common Equity	1,841	1,844	2,028	2,274	2,638	3,019
Minority Interest	13.01	13.61	16.56	-0.03	-	-
Shareholders' Equity	1,854	1,858	2,045	2,274	2,638	3,019
Total Liabilities & Equity	2,914	2,657	2,689	2,672	3,316	3,164

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	652.69	434.03	253.4	221.14	131.88	7.63
Net Cash (Debt)	108.43	126.23	459.12	721.79	1,611	2,290
Net Cash Growth	-61.20%	-72.51%	-36.39%	-55.20%	-29.65%	-6.68%
Net Cash Per Share	0.16	0.19	0.69	1.06	2.39	3.46
Filing Date Shares Outstanding	672.63	669.51	665.19	675.51	672.2	666.69
Total Common Shares Outstanding	672.63	669.51	665.19	675.51	672.2	666.69
Working Capital	396.65	143.06	544.3	1,083	1,429	2,308
Book Value Per Share	2.74	2.75	3.05	3.37	3.92	4.53
Tangible Book Value	1,166	1,160	1,402	1,746	2,099	2,743
Tangible Book Value Per Share	1.73	1.73	2.11	2.59	3.12	4.11
Buildings	643.64	434.15	433.17	61.97	53.56	53.53
Machinery	199.1	195.2	184.28	152.79	109.64	76.51
Construction In Progress	0.83	206.24	122.31	290.45	167.41	28.61
Leasehold Improvements	55.34	55.17	40.72	39.11	38.6	31.06